Cross-examination ends in TPA patent case.
D010330:Patents as Topic / Q000331:legislation & jurisprudence*; D011994:Recombinant Proteins / Q000096:biosynthesis*; D010959:Tissue Plasminogen Activator / Q000096:biosynthesis*; D006113:United Kingdom
D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator